HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

peptide I

15-amino acid sequence given in first source; part of a receptor for protein kinase C (RACK)
Also Known As:
RACK1 (peptide)
Networked: 28 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Agten, Stijn M: 1 article (01/2022)
2. Aslani, Maria: 1 article (01/2022)
3. Blanchet, Xavier: 1 article (01/2022)
4. Brandl, Richard: 1 article (01/2022)
5. Chitneni, Satish K: 1 article (01/2022)
6. Duan, Rundan: 1 article (01/2022)
7. Duchene, Johan: 1 article (01/2022)
8. Döring, Yvonne: 1 article (01/2022)
9. Hackeng, Tilman M: 1 article (01/2022)
10. Heemskerk, Johan W M: 1 article (01/2022)

Related Diseases

1. Thrombosis (Thrombus)
2. Mastitis
3. Neoplasms (Cancer)
01/01/2022 - "The resulting labeled peptide [*I]SIB-VIP116 exhibited high uptake (165.3 ± 27.7%/mg protein) and specificity in SJSA-1 tumor cells. "
10/15/2012 - "We show that the IRDye 800CW-RGD peptide: (i) specifically binds to integrin receptors; (ii) is selectively localized to glioblastoma tissue with overexpressed integrin receptors and is retained over prolonged periods of time; (iii) is associated with minimal autofluorescence and photobleaching because of imaging at 800 nm; (iv) provides delineation of tumor tissue with high precision because of a high tumor-to-normal brain fluorescence ratio (79.7 ± 6.9, 31.2 ± 2.8, and 16.3 ± 1.3) in the U-87 MG, RCAS-PDGF, and TS543 models, respectively; P < 0.01); and (v) enables fluorescence-guided glioblastoma resection. "
12/15/1997 - "Third, both Ag-specific, MHC class II (DQ)-restricted CD4+ and MHC class I-restricted (HLA-A2) CD8+ T cell lines were generated from a single patient with duodenal carcinoma whose primary tumor contained a Val12 mutation when cultured on the immunizing 13-mer peptide or a nested 10-mer peptide [i.e., ras5-14(Val12)], respectively. "
07/01/2020 - "Of note, both CK2-mediated inhibitory mechanisms of this anticancer peptide (i.e., substrate- and enzyme-binding mechanism) may run in parallel in tumor cells and help to explain the different anti-neoplastic effects exerted by CIGB-300 in preclinical cancer models."
01/01/2019 - "Overall, the study shows that GM15 peptide i) scavenges superoxide, hydroxyl radicals, and influences intracellular oxidative stress, and ii) has anti-cancer effect in oral cancer cells."
4. Mouth Neoplasms (Oral Cancer)
5. Inflammation (Inflammations)

Related Drugs and Biologics

1. Peptides (Polypeptides)
2. Hydroxyl Radical
3. Superoxides (Superoxide)
4. Calcium Hydroxide
5. dentin sialophosphoprotein
6. aspartic acid glycine arginine
7. Amyloid (Amyloid Fibrils)
8. Adiponectin
9. Proteins (Proteins, Gene)
10. Neurogranin

Related Therapies and Procedures

1. Therapeutics
2. Injections